Rothschild's Five Arrows backs Swedish pet health firm Vetz Petz
What's the deal? Five ArrowsDealroom has a profile for this one. Try Dealroom → has made a growth equity investment in Vetz PetzDealroom has a profile for this one. Try Dealroom →, a Swedish animal health company, in a deal that closed on September 14, 2026. Five Arrows is the alternative assets arm of Rothschild & CoDealroom has a profile for this one. Try Dealroom →, which manages more than €13 billion of capital. Simpson ThacherDealroom has a profile for this one. Try Dealroom → advised the lenders on the financing.
What does Vetz Petz do? Founded in 2011, it distributes the AntinolDealroom has a profile for this one. Try Dealroom → brand, a nutraceutical supplement designed to manage joint and mobility care in pets. The company operates primarily in Japan, Australia, and Thailand, with its global headquarters in Sweden.
What's the endgame? The investment aims to accelerate international growth, diversify Vetz Petz's product range, and fund strategic acquisitions.
Why Five Arrows? Its corporate private equity business backs healthcare, data, software, and technology-enabled business services companies across Europe and North America. It invests through funds focused on the lower mid-market, mid-market, and upper mid-market.
The signal: The deal points to sustained private equity appetite for the pet care sector, where recurring-revenue supplement brands and cross-border distribution networks continue to draw institutional capital.
Read more: stblaw.com
Image credit: Aiko, Thomas & Juliette+Isaac
